Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial

OBJECTIVE: T-cell activation independently predicts mortality, poor immune recovery and non-AIDS illnesses during combination antiretroviral therapy (cART). Atorvastatin showed anti-immune activation effects among HIV-infected cART-naïve individuals. We investigated whether adjunct atorvastatin ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanjako, Damalie, Ssinabulya, Isaac, Nabatanzi, Rose, Bayigga, Lois, Kiragga, Agnes, Joloba, Moses, Kaleebu, Pontiano, Kambugu, Andrew D., Kamya, Moses R., Sekaly, Rafick, Elliott, Alison, Mayanja-Kizza, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529480/
https://www.ncbi.nlm.nih.gov/pubmed/25441397
http://dx.doi.org/10.1111/tmi.12442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529480/
https://www.ncbi.nlm.nih.gov/pubmed/25441397
http://dx.doi.org/10.1111/tmi.12442

Ejemplares similares